Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Genomic Profiling of Circulating Tumor DNA Reveals Patterns of Response and Refractoriness in Aggressive B-Cell Lymphoma - a Nordic Lymphoma Group Correlative Study

Leo Meriranta, MD, Amjad Alkodsi, PhD, Annika Pasanen, MD PhD, Maija Lepistö, MSc, Yngvild Nuvin Blaker, MD PhD, Matias Autio, Judit Jørgensen, MD PhD, Mats Jerkeman, MD Professor, Harald Holte, MD PhD, Pekka Ellonen, BSc, Sirpa Leppa, MD Prof

Blood (2019) 134 (Supplement_1): 1481.

https://doi.org/10.1182/blood-2019-132168

Published: 2019

Journal Articles

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Kristian Løvvik Juul-Dam, MD, Erik Delsing Malmberg, Anna Rehammar, Erik Kristiansson, Jonas Abrahamsson, Anni Aggerholm, Marta Maria Dirdal, Kirsi Jahnukainen, Birgitte Lausen, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2019) 134 (Supplement_1): 1456.

https://doi.org/10.1182/blood-2019-124970

Published: 2019

Journal Articles

Real-World Effectiveness and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) in Previously Treated Patients with Hemophilia A (HEM-POWR): Online Patient Portal and LIFE-ACTIVE Sub-Study

Johannes Oldenburg, María Teresa Alvarez Román, Giancarlo Castaman, Maissaa Janbain, MD, Tadashi Matsushita, Karina Meijer, Sabine Friedl, Martin Sanabria, Mark Reding

Blood (2019) 134 (Supplement_1): 4943.

https://doi.org/10.1182/blood-2019-128140

Published: 2019

Journal Articles

Spatio-Temporal Clustering of Childhood Leukemia Relative to Population Mixing in Finland: A Nationwide Register-Based Study

Atte Nikkilä, MD, Jani Raitanen, MSc, Olli Lohi, MD PhD, Anssi Auvinen, MD PhD

Blood (2019) 134 (Supplement_1): 5070.

https://doi.org/10.1182/blood-2019-125930

Published: 2019

Journal Articles

Combination of TREC Measurement and Next-Generation Sequencing in Newborn Screening for Severe Combined Immunodeficiency: A Pilot Program in Japan

Hideki Muramatsu, MD PhD, Daiei Kojima, MD, Yusuke Okuno, MD PhD, Shinsuke Kataoka, MD, Yoko Nakajima, Tetsuya Ito, Ikuya Tsuge, Sakai Yoshimi, Tomoaki Kato, Seiji Kojima, MD PhD, Yoshiyuki Takahashi, MD, PhD

Blood (2018) 132 (Supplement 1): 3717.

https://doi.org/10.1182/blood-2018-99-118261

Published: 2018

Journal Articles

Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML

Brian S. White, PhD, Suleiman A. Khan, PhD, Muhammad Ammad-ud-din, PhD, Swapnil Potdar, MSc, Mike J Mason, PhD, Cristina E. Tognon, PhD, Brian J. Druker, MD, Caroline A Heckman, PhD, Olli Kallioniemi, MD PhD, Stephen E Kurtz, PhD, Kimmo Porkka, MD PhD, Jeffrey W. Tyner, PhD, Tero Aittokallio, PhD, Krister Wennerberg, PhD, Justin Guinney, PhD

Blood (2018) 132 (Supplement 1): 2763.

https://doi.org/10.1182/blood-2018-99-111916

Published: 2018

Journal Articles

Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era

Roosa Enni Inkeri Prusila, Marc Sorigue, Aleksi Postila, Petteri Salmi, Taru Tanhua, Susanna Tikkanen, Sakari Kakko, Hanne Kuitunen, Marjukka Pollari, Ilja Nystrand, Milla Kuusisto, Kaija Vasala, Esa Jantunen, Eija Korkeila, Peeter Karihtala, Taina Turpeenniemi-Hujanen, Outi Kuittinen

Blood (2018) 132 (Supplement 1): 5330.

https://doi.org/10.1182/blood-2018-99-110129

Published: 2018

Journal Articles

Reduced Intensity Conditioned Sibling Transplantation Versus No Transplant in Intermediate or High Risk Acute Myeloid Leukemia: A Prospective Multi-Center Study in Patients 50-70 Years in First Complete Remission and with at Least One Potential Sibling Donor ( ClinTrialGov 00342316 )

Mats Brune, MD PhD, Thomas L. Kiss, MD, Elisabeth Wallhult, RN, Harald Anderson, PhD, Robert Delage, MD, Jürgen Finke, MD, Josee Hebert, MD, Martin Höglund, MD PhD, Ain Kaare, MD, Vladimir Lazarevic, MD PhD, Malin Nicklasson, MSc, Kari Remes, MD PhD, David Ritchie, MBChB, PhD FRACP, FRCPA, Mitchell Sabloff, MD, Ruth Spearing, MD, Alexandros Spyridonidis, MD PhD, Jeffrey Szer, MBBS, Per Ljungman, MD PhD

Blood (2018) 132 (Supplement 1): 205.

https://doi.org/10.1182/blood-2018-99-110260

Published: 2018

Journal Articles

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Fie Juhl Vojdeman, MD, Lone Bredo Pedersen, Doreen Te Raa, MD PhD, Vesa Juvonen, PhD, Yvette Norden, Geir Erland Tjønnfjord, MD DMsc, Eva Kimby, Maija Itälä-Remes, MD PhD, Anton W Langerak, Ludo M. Evers, Thorsten Zenz, MD, Marinus H.J. Van Oers, MD PhD, Christian H. Geisler, MD PhD, Arnon P. Kater, MD, Carsten Utoft Niemann, MD PhD

Blood (2017) 130 (Supplement 1): 4312.

https://doi.org/10.1182/blood.V130.Suppl_1.4312.4312

Published: 2017

Journal Articles

Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016

Blood (2017) 130 (Supplement 1): 272.

https://doi.org/10.1182/blood.V130.Suppl_1.272.272

Published: 2017

Journal Articles

Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol

Cecilie Rank, MD, Nina Toft, MD PhD, Ruta Tuckuviene, MD PhD, Kathrine Grell, PhD, Ove Juul Nielsen, MD DMSc, Thomas Leth Frandsen, MD PhD, Ulf Tedgaard, MD PhD, Helene Hallböök, MD PhD, Ellen Ruud, MD PhD, Petter Quist-Paulsen, MD PhD, Kaisa Vepsäläinen, MD, Ulla Wartiovaara-Kautto, MD PhD, Ólafur G. Jónsson, MD, Sonata Saulyte Trakymiene, MD, Laimonas Griškevičius, MD PhD, Kadri Saks, MD, Mari Punab, MD, Kjeld Schmiegelow, MD DMSc

Blood (2017) 130 (Supplement 1): 2564.

https://doi.org/10.1182/blood.V130.Suppl_1.2564.2564

Published: 2017

Journal Articles

A Novel System for Newborn Screening of Thalassemia and Hemoglobinopathies Using Capillary Electrophoresis Is Superior Than Isoelectric Focusing

Thidarat Suksangpleng, PhD, Suchada Riolueang, M.Sc., Jiraporn Korchuenjit, B.Sc., Wasamon Korchuenjit, M.Sc., Julaporn Pooliam, M.Sc., Vip Viprakasit, MD DPhil

Blood (2017) 130 (Supplement 1): 2089.

https://doi.org/10.1182/blood.V130.Suppl_1.2089.2089

Published: 2017

Journal Articles

Real-World Outcomes of Chemoimmunotherapy in Chronic Lymphocytic Leukemia (CLL) Clinical Practice: Results from a Decade of Practice in Helsinki 2005-2015

Vesa Lindström, MD, Tiina M Jarvinen, Juha Mehtälä, Houssem Khanfir, Rosa Juuti, Amy Leval, PhD, Marjaana Säily, MD PhD

Blood (2017) 130 (Supplement 1): 5663.

https://doi.org/10.1182/blood.V130.Suppl_1.5663.5663

Published: 2017

Journal Articles

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

Manuel Carcao, Carmen Altisent, PhD, Giancarlo Castaman, Katsuyuki Fukutake, MD PhD, Aida Inbal, MD, Bryce A. Kerlin, Craig M. Kessler, MD, Riitta Lassila, MD PhD, Johannes Oldenburg, Prof, Anders Rosholm, May-Lill Garly, MD PhD, Diane J. Nugent, MD

Blood (2016) 128 (22): 2573.

https://doi.org/10.1182/blood.V128.22.2573.2573

Published: 2016

Journal Articles

Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial

Mats Jerkeman, Martin Hutchings, Riikka Räty, Karin Fahl Wader, Anna Laurell, Hanne Kuitunen, Helle Toldbod, Lone Bredo Pedersen, Christian Winther Eskelund, Kirsten Grønbæk, Carsten Utoft Niemann, Christian H Geisler, Arne Kolstad

Blood (2016) 128 (22): 148.

https://doi.org/10.1182/blood.V128.22.148.148

Published: 2016

Journal Articles

Response at Interim Evaluation Predicts Survival after Autologous Stem Cell Transplantation in Nodal Peripheral T-Cell Lymphoma; A Nordic Lymphoma Group Study

Fredrik Ellin, MD PhD, Knut Liestøl, Susanna Mannisto, Grete F Lauritzsen, MD, Esa Jantunen, MD PhD, Peter A Meyer, Helle Toldbod, Thomas Relander, MD PhD, Francesco A d'Amore, MD

Blood (2016) 128 (22): 1830.

https://doi.org/10.1182/blood.V128.22.1830.1830

Published: 2016

Journal Articles

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Ondrej Hrusak, MD PhD, Valerie De Haas, MD PhD, Ales Luks, Iveta Janotova, Ester Mejstrikova, MD PhD, Kirsten Bleckmann, MD, Anja Moricke, MD, Julie Irving, PhD, Benigna Konatkowska, Thomas B. Alexander, MD MPH, Hiroto Inaba, MD PhD, Kjeld Schmiegelow, MD DMSc, Simone Stokley, FRCPath,, Jorge Gabriel Rossi, PhD, Maria Sara Felice, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Jessa Morales, Michael Dworzak, MD, Barbara Buldini, MD, Giuseppe Basso, Myriam Campbell, Maria Elena Cabrera, Neda Marinov, Sarah Elitzur, MD, Shai Izraeli, MD, Drorit Luria, PhD, Tamar Feuerstein, PhD, Alexandra Kolenova, MD PhD, Peter Svec, Elena Kreminska, Karen R. Rabin, MD, Sophia Polychronopoulou, MD PhD, Elaine da Costa, Hanne Vibeke Marquart, MD PhD, Antonis Kattamis, MD, Richard Ratei, Dirk Reinhardt, MD PhD, Anthony V Moorman, PhD, Martin Schrappe, MD, Jan Stary, MD D.Sc.

Blood (2016) 128 (22): 584.

https://doi.org/10.1182/blood.V128.22.584.584

Published: 2016

Journal Articles

Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database

Samu Kurki, PhD, Klaus Tamminen, MD, Tatu Miettinen, MD, Kari Remes, MD PhD

Blood (2016) 128 (22): 5645.

https://doi.org/10.1182/blood.V128.22.5645.5645

Published: 2016

Journal Articles

Novel Mutations in Patients with Blast Crisis or Accelerated Phase Chronic Myeloid Leukemia

Shady Adnan Awad, MD, Matti Kankainen, PhD, Samuli Eldfors, MSc, Soili Kytölä, PhD, Pekka Ellonen, Mahmoud Kamel, MD PhD, Caroline A Heckman, PhD, Kimmo Porkka, MD PhD, Satu Mustjoki, MD PhD

Blood (2016) 128 (22): 1924.

https://doi.org/10.1182/blood.V128.22.1924.1924

Published: 2016

Journal Articles

Impact of Rituximab and Methotrexate on the Survival of the Patients with Sinonasal Tract Diffuse Large B-Cell Lymphoma

Pauli Vähämurto, MD, Susanna Mannisto, Marjukka Pollari, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Antti A. Mäkitie, MD PhD, Sirpa Leppä, MD PhD

Blood (2016) 128 (22): 1859.

https://doi.org/10.1182/blood.V128.22.1859.1859

Published: 2016

NARROW

Genomic Profiling of Circulating Tumor DNA Reveals Patterns of Response and Refractoriness in Aggressive B-Cell Lymphoma - a Nordic Lymphoma Group Correlative Study

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Real-World Effectiveness and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) in Previously Treated Patients with Hemophilia A (HEM-POWR): Online Patient Portal and LIFE-ACTIVE Sub-Study

Spatio-Temporal Clustering of Childhood Leukemia Relative to Population Mixing in Finland: A Nationwide Register-Based Study

Combination of TREC Measurement and Next-Generation Sequencing in Newborn Screening for Severe Combined Immunodeficiency: A Pilot Program in Japan

Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML

Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era

Reduced Intensity Conditioned Sibling Transplantation Versus No Transplant in Intermediate or High Risk Acute Myeloid Leukemia: A Prospective Multi-Center Study in Patients 50-70 Years in First Complete Remission and with at Least One Potential Sibling Donor ( ClinTrialGov 00342316 )

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016

Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol

A Novel System for Newborn Screening of Thalassemia and Hemoglobinopathies Using Capillary Electrophoresis Is Superior Than Isoelectric Focusing

Real-World Outcomes of Chemoimmunotherapy in Chronic Lymphocytic Leukemia (CLL) Clinical Practice: Results from a Decade of Practice in Helsinki 2005-2015

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial

Response at Interim Evaluation Predicts Survival after Autologous Stem Cell Transplantation in Nodal Peripheral T-Cell Lymphoma; A Nordic Lymphoma Group Study

Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies

Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database

Novel Mutations in Patients with Blast Crisis or Accelerated Phase Chronic Myeloid Leukemia

Impact of Rituximab and Methotrexate on the Survival of the Patients with Sinonasal Tract Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only